Editas Medicine Inc
NASDAQ:EDIT
Wall Street
Price Targets
EDIT Price Targets Summary
Editas Medicine Inc
According to Wall Street analysts, the average 1-year price target for EDIT is 16.17 USD with a low forecast of 7.07 USD and a high forecast of 28.35 USD.
EDIT Last Price Targets
Editas Medicine Inc
The latest public price target was made on Sep 28, 2023 by Dae Gon Ha from Stifel Nicolaus , who expects EDIT stock to rise by 129% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.
Analyst | Price Target | Date | Article |
---|---|---|---|
Dae Gon Ha
Stifel Nicolaus
|
17
USD
Upside 129% |
6 months ago
Sep 28, 2023
|
Stifel Upgrades Editas Medicine (EDIT) to Buy, 'Difficult To Justify Current Valuation'
StreetInsider
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is EDIT's stock price target?
Price Target
16.17
USD
According to Wall Street analysts, the average 1-year price target for EDIT is 16.17 USD with a low forecast of 7.07 USD and a high forecast of 28.35 USD.
What is Editas Medicine Inc's Revenue forecast?
Projected CAGR
-4%
For the last 8 years the compound annual growth rate for Editas Medicine Inc's revenue is 62%. The projected CAGR for the next 3 years is -4%.